iRhythm Holdings (IRTC) Income from Continuing Operations (2015 - 2026)
iRhythm Holdings (IRTC) posted quarterly Income from Continuing Operations of 13933000.0 for Q1 2026, up 54.62% year-over-year from 9011378.43 in Q1 2025, and down 349.74% quarter-over-quarter from 5579000.0 in Q4 2025.
iRhythm Holdings (IRTC) Income from Continuing Operations (2015 - 2026) Analysis & Trends
iRhythm Holdings (IRTC) has reported Income from Continuing Operations for 12 consecutive years, with 13933000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 54.62% year-over-year to 13933000.0; the TTM figure through Mar 2026 stood at 27784000.0 (up 71.74% YoY), while the FY2025 annual figure was 44551000.0, up 60.67% from the prior year.
- Income from Continuing Operations declined to 13933000.0 in Q1 2026 per IRTC's latest filing, from 5579000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 5579000.0 in Q4 2025 and bottomed at 50609000.0 in Q1 2022.
- Historically, Income from Continuing Operations has averaged 24196117.65 across 5 years, with a median of 21451000.0 in 2022.
- Annual changes were most pronounced in 2023 — Income from Continuing Operations sank 91.6% — and 2025, when it surged 518.53%.
- iRhythm Holdings' Income from Continuing Operations stood at 20198000.0 in 2022, then tumbled by 91.6% to 38699000.0 in 2023, then jumped by 96.56% to 1333000.0 in 2024, then soared by 518.53% to 5579000.0 in 2025, then tumbled by 349.74% to 13933000.0 in 2026.
- Business Quant data shows IRTC's Income from Continuing Operations at 13933000.0 in Q1 2026, 5579000.0 in Q4 2025, and 5212000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 201.00 Mn |
| 10 | iRhythm Holdings | 4.22 Bn | 3.63 Bn | 163.21 Mn | -381,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -381,000.00 |
| Mar 31, 2026 | -13.93 Mn |
| Dec 31, 2025 | 5.58 Mn |
| Sep 30, 2025 | -5.21 Mn |
| Jun 30, 2025 | -14.22 Mn |
| Mar 31, 2025 | -30.70 Mn |
| Dec 31, 2024 | -1.33 Mn |
| Sep 30, 2024 | -46.18 Mn |
| Jun 30, 2024 | -20.11 Mn |
| Mar 31, 2024 | -45.67 Mn |
| Dec 31, 2023 | -38.70 Mn |
| Sep 30, 2023 | -27.12 Mn |
| Jun 30, 2023 | -18.48 Mn |
| Mar 31, 2023 | -39.11 Mn |
| Dec 31, 2022 | -20.20 Mn |
| Sep 30, 2022 | -21.45 Mn |
| Jun 30, 2022 | -23.90 Mn |
| Mar 31, 2022 | -50.61 Mn |
| Dec 31, 2021 | -32.49 Mn |
| Sep 30, 2021 | -23.73 Mn |